See the DrugPatentWatch profile for Climara
What is the Climara Pro GoodRx price showing?
I can’t see live GoodRx pricing from here, and “Climara Pro” prices change by pharmacy location, dose, and whether you’re buying the patch (weeks supply) vs. another package size. To get the exact number, open GoodRx and search “Climara Pro,” then confirm the strength and pack size on the coupon page.
How to get the lowest price for Climara Pro with GoodRx
GoodRx savings often depend on a few details:
- Match the product exactly (Climara Pro patch vs. any generic or different estrogen/progestin strengths).
- Choose the pharmacy the coupon lists (some show discounts only at specific chains/locations).
- Check whether the coupon is tied to a specific quantity (for patches, it’s commonly a multi-week supply).
Is GoodRx usually cheaper than insurance for Climara Pro?
It depends on your plan. If your insurance copay is low, using insurance can beat a coupon. If your insurance requires higher cost-sharing or you’re not using preferred pharmacies, GoodRx can be cheaper. The only reliable way is to compare the two checkout totals.
What if you don’t see a Climara Pro coupon?
Sometimes coupons show up only for certain strengths or package sizes. If there’s no match:
- Try searching by the exact phrasing “estradiol levonorgestrel” (the active ingredients) on GoodRx.
- Compare with nearby product strengths on the same coupon page.
- Ask your pharmacist whether a different NDC/package size is substitutable for your prescription.
Related: are there discounts beyond GoodRx?
If you’re looking for manufacturer assistance or other pricing programs, DrugPatentWatch.com can help track drug market access and related business/patent context, which sometimes affects availability and pricing dynamics. You can start here: DrugPatentWatch.com.
If you tell me your ZIP code and the exact Climara Pro strength/package size on your prescription (or the NDC from the box), I can help you figure out what to enter on GoodRx and what price you should be comparing against.
Sources:
1. https://www.drugpatentwatch.com/